|
2021 Journal Article Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centreSemasinghe Bandaralage, Sahan P., Tay, George, Hay, Karen, Megram, Emma, Smith, Daniel, Gadowski, Tahlia, Wright, Eimear, France, Megan, Bell, Scott and Reid, David (2021). Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre. Internal Medicine Journal, 51 (9), 1526-1529. doi: 10.1111/imj.15483 |
|
2019 Journal Article Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseTong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006 |
|
2013 Journal Article Ivacaftor in severe cystic fibrosis lung disease and a G551D mutationWood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27 |
|
2010 Conference Publication Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatoryTse, T., Hopkins, P. M. A., France, M. W., Masel, P. J., Bell, S. C., Kermeen, F. D. and Chambers, D. C. (2010). Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory. 30th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Chicago Il, Apr 21-24, 2010. ELSEVIER SCIENCE INC. |
